Subscribe
shutterstock_1427467406_art_studio_g
23 September 2021Jurisdiction reportsNaomi Pearce

Strategies for generic/biosimilar market entry in Australia

The pharma/biopharma industry shouldn’t underestimate the importance of strategising to achieve early market entry for generics and biosimilars, says Naomi Pearce of Pearce IP.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
DABUS: decoding Australia’s AI decision
10 August 2021   Allowing an AI as an inventor could benefit the country’s pharma and drug discovery industries, say Richard Hamer, Lauren John and Alexandra Moloney of Allens.
Patents
Australia to safeguard tech IP by policing foreign R&D
11 March 2021   Australia has unveiled plans to expand the technologies in which international research and development collaboration will face increased scrutiny to protect the country’s IP.


Editor's picks

Copyright
‘We were on tenterhooks’: Winning counsel dives into WaterRower
18 November 2024

Editor's picks

Copyright
‘We were on tenterhooks’: Winning counsel dives into WaterRower
18 November 2024
Unified Patent Court
UPC docs 'excessively redacted' under GDPR claims transparency lawyer
15 November 2024
Trademarks
SkyKicked: How a bad faith ruling put the boot into big brands
14 November 2024
Artificial Intelligence
Perplexity lawsuit sees rightsholders deploy new feature
24 October 2024
Copyright
‘Modding video games still unlawful’ after Sony defeat in EU court
23 October 2024
Patents
President Xi sends message to AIPPI’s World Congress
21 October 2024

More articles

UK firms Venner Shipley and AA Thornton combine
UPC docs 'excessively redacted' under GDPR claims transparency lawyer
L'Oréal sued over virtual makeup try-on simulator
Kathi Vidal to leave USPTO ahead of incoming Trump administration
Q&A: EagleView counsel maps out route to IPR victory
WIPO in Saudi Arabia to finalise design law treaty
Douwe Egberts enjoys double shot over Nestlé in coffee patent rivalry
Startup CFO’s betrayal is a lesson in preparing for the worst